Man Group PLC Acadia Pharmaceuticals Inc Transaction History

Man Group PLC

$36 Billion
Q3 2024

A detailed history of Man Group PLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Man Group PLC holds 1,275,433 shares of ACAD stock, worth $20.9 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

1,275,433

Previous 57,145 2131.92%

Holding current value

$20.9 Million

Previous $928,000 2015.09%

% of portfolio

0.05%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$15.14 - $19.14 $18.4 Million - $23.3 Million	1,218,288 Added 2131.92%	1,275,433 $19.6 Million
Q2 2024 Aug 14, 2024	BUY	$14.62 - $18.42 $100,059 - $126,066	6,844 Added 13.61%	57,145 $928,000
Q1 2024 May 15, 2024	BUY	$17.79 - $30.86 $321,660 - $557,979	18,081 Added 56.12%	50,301 $930,000
Q4 2023 Feb 14, 2024	SELL	$20.78 - $31.77 $977,491 - $1.49 Million	-47,040 Reduced 59.35%	32,220 $1.01 Million
Q3 2023 Nov 14, 2023	SELL	$20.84 - $33.47 $4.12 Million - $6.62 Million	-197,936 Reduced 71.41%	79,260 $1.65 Million
Q2 2023 Aug 14, 2023	SELL	$17.8 - $25.65 $7.11 Million - $10.2 Million	-399,596 Reduced 59.04%	277,196 $6.64 Million
Q1 2023 May 15, 2023	SELL	$16.32 - $20.92 $4.55 Million - $5.83 Million	-278,896 Reduced 29.18%	676,792 $12.7 Million
Q4 2022 Feb 14, 2023	BUY	$14.2 - $18.63 $13.2 Million - $17.4 Million	932,503 Added 4022.01%	955,688 $15.2 Million
Q3 2022 Nov 14, 2022	BUY	$14.11 - $18.27 $327,140 - $423,589	23,185 New	23,185 $379,000
Q2 2022 Aug 15, 2022	SELL	$13.01 - $27.22 $252,862 - $529,047	-19,436 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$20.94 - $27.5 $406,989 - $534,490	19,436 New	19,436 $470,000
Q1 2021 May 17, 2021	SELL	$25.02 - $54.99 $1.25 Million - $2.76 Million	-50,129 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$41.04 - $56.79 $374,736 - $518,549	-9,131 Reduced 15.41%	50,129 $2.68 Million
Q3 2020 Nov 16, 2020	SELL	$36.42 - $57.0 $2.05 Million - $3.2 Million	-56,160 Reduced 48.66%	59,260 $2.44 Million
Q2 2020 Aug 14, 2020	BUY	$39.26 - $52.73 $2.58 Million - $3.47 Million	65,835 Added 132.77%	115,420 $5.59 Million
Q1 2020 May 15, 2020	SELL	$31.65 - $46.87 $1.19 Million - $1.77 Million	-37,732 Reduced 43.21%	49,585 $2.1 Million
Q4 2019 Feb 18, 2020	BUY	$36.21 - $51.4 $3.16 Million - $4.49 Million	87,317 New	87,317 $3.74 Million
Q2 2019 Aug 14, 2019	SELL	$23.32 - $28.12 $1.12 Million - $1.36 Million	-48,215 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$16.17 - $27.38 $26,615 - $45,067	-1,646 Reduced 3.3%	48,215 $1.29 Million
Q4 2018 Feb 14, 2019	BUY	$14.32 - $22.92 $714,009 - $1.14 Million	49,861 New	49,861 $806,000
Q2 2018 Aug 14, 2018	SELL	$15.07 - $22.34 $95,151 - $141,054	-6,314 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$22.47 - $32.33 $141,875 - $204,131	6,314 New	6,314 $142,000

Others Institutions Holding ACAD

# of Institutions

280

Shares Held

156M

Call Options Held

901K

Put Options Held

314K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.65B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Account